218 related articles for article (PubMed ID: 12926143)
1. Loss of heterozygosity in ampulla of Vater neoplasms during adenoma-carcinoma sequence.
Park S; Kim SW; Kim SH; Lee BL; Kim WH
Anticancer Res; 2003; 23(3C):2955-9. PubMed ID: 12926143
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity in dysplasia and carcinoma of the gallbladder.
Chang HJ; Kim SW; Kim YT; Kim WH
Mod Pathol; 1999 Aug; 12(8):763-9. PubMed ID: 10463477
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.
Shao JY; Huang XM; Yu XJ; Huang LX; Wu QL; Xia JC; Wang HY; Feng QS; Ren ZF; Ernberg I; Hu LF; Zeng YX
Anticancer Res; 2001; 21(4B):3021-9. PubMed ID: 11712805
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetic alterations in carcinoma ex-pleomorphic adenoma: a putative progression model?
El-Naggar AK; Callender D; Coombes MM; Hurr K; Luna MA; Batsakis JG
Genes Chromosomes Cancer; 2000 Feb; 27(2):162-8. PubMed ID: 10612804
[TBL] [Abstract][Full Text] [Related]
5. Allelotype of the adenoma-carcinoma sequence of the stomach.
Kim HS; Woo DK; Bae SI; Kim YI; Kim WH
Cancer Detect Prev; 2001; 25(3):237-44. PubMed ID: 11425265
[TBL] [Abstract][Full Text] [Related]
6. Differences in mucus and K-ras mutation in relation to phenotypes of tumors of the papilla of vater.
Matsubayashi H; Watanabe H; Yamaguchi T; Ajioka Y; Nishikura K; Kijima H; Saito T
Cancer; 1999 Aug; 86(4):596-607. PubMed ID: 10440687
[TBL] [Abstract][Full Text] [Related]
7. Distinct chromosomal aberrations of ampulla of Vater and pancreatic head cancers detected by laser capture microdissection and comparative genomic hybridization.
Chang MC; Chang YT; Tien YW; Sun CT; Wu MS; Lin JT
Oncol Rep; 2005 Oct; 14(4):867-72. PubMed ID: 16142344
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity in the clonal evolution of flat colorectal neoplasms.
Fujii H; Ajioka Y; Kazami S; Takagaki T; Gong Zhu X; Hirose S; Watanabe H; Shirai T
J Pathol; 2002 Jul; 197(3):298-306. PubMed ID: 12115875
[TBL] [Abstract][Full Text] [Related]
9. K-ras mutation in adenomas and carcinomas of the ampulla of vater.
Howe JR; Klimstra DS; Cordon-Cardo C; Paty PB; Park PY; Brennan MF
Clin Cancer Res; 1997 Jan; 3(1):129-33. PubMed ID: 9815548
[TBL] [Abstract][Full Text] [Related]
10. Different profiles of allelic losses in cervical carcinoma cases in Surinam and The Netherlands.
Krul EJ; Kersemaekers AM; Zomerdijk-Nooyen YA; Cornelisse CJ; Peters LA; Fleuren GJ
Cancer; 1999 Sep; 86(6):997-1004. PubMed ID: 10491526
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity analysis in uterine cervical adenocarcinoma.
Miyai K; Furugen Y; Matsumoto T; Iwabuchi K; Hirose S; Kinoshita K; Fujii H
Gynecol Oncol; 2004 Jul; 94(1):115-20. PubMed ID: 15262128
[TBL] [Abstract][Full Text] [Related]
12. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia.
Rosin MP; Cheng X; Poh C; Lam WL; Huang Y; Lovas J; Berean K; Epstein JB; Priddy R; Le ND; Zhang L
Clin Cancer Res; 2000 Feb; 6(2):357-62. PubMed ID: 10690511
[TBL] [Abstract][Full Text] [Related]
13. Allelic loss on chromosomes 8 and 9 correlates with clinical outcome in locally advanced clear cell carcinoma of the kidney.
Presti JC; Wilhelm M; Reuter V; Russo P; Motzer R; Waldman F
J Urol; 2002 Mar; 167(3):1464-8. PubMed ID: 11832771
[TBL] [Abstract][Full Text] [Related]
14. Carcinoma of the ampulla of Vater associated with or without adenoma: a clinicopathologic analysis of 198 cases with reference to p53 and Ki-67 immunohistochemical expressions.
Takashima M; Ueki T; Nagai E; Yao T; Yamaguchi K; Tanaka M; Tsuneyoshi M
Mod Pathol; 2000 Dec; 13(12):1300-7. PubMed ID: 11144926
[TBL] [Abstract][Full Text] [Related]
15. [Development of carcinoma of Vater's ampulla in an adenoma. Analysis of a personal case load and review of the literature].
Sellner F; Machacek E
Wien Klin Wochenschr; 1986 Mar; 98(6):182-7. PubMed ID: 3705596
[TBL] [Abstract][Full Text] [Related]
16. Distinct allelic loss patterns in papillary serous carcinoma of the peritoneum.
Huang LW; Garrett AP; Schorge JO; Muto MG; Bell DA; Welch WR; Berkowitz RS; Mok SC
Am J Clin Pathol; 2000 Jul; 114(1):93-9. PubMed ID: 10884804
[TBL] [Abstract][Full Text] [Related]
17. [Molecular genetic progression on nasopharyngeal carcinoma].
Shao JY; Zeng WF; Zeng YX
Ai Zheng; 2002 Jan; 21(1):1-10. PubMed ID: 12500388
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive loss of heterozygosity analysis and identification of a novel hotspot at 3p21 in salivary gland neoplasms.
Honjo N; Gunduz M; Fukushima K; Cengiz B; Beder LB; Gunduz E; Nagatsuka H; Xiao J; Shimizu K; Nishizaki K
Otolaryngol Head Neck Surg; 2007 Jul; 137(1):119-25. PubMed ID: 17599578
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity during the development and progression of differentiated adenocarcinoma of the stomach.
Nishizuka S; Tamura G; Terashima M; Satodate R
J Pathol; 1998 May; 185(1):38-43. PubMed ID: 9713358
[TBL] [Abstract][Full Text] [Related]
20. Fractional allelic loss in gastric carcinoma correlates with growth patterns.
Choi SW; Park SW; Lee KY; Kim KM; Chung YJ; Rhyu MG
Oncogene; 1998 Nov; 17(20):2655-9. PubMed ID: 9840929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
